InfraReDx’s Long Road To Commercialization Continues With Latest Financing

InfraReDx raised $25 million in late August, another step in its long journey to change the standard of care for coronary artery disease. With the latest financing, the company has raised some $175 million since its founding in 1998, and although it still has far to go, in that length of time InfraReDx, and an understanding of coronary artery disease, have come a long way.